GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Schott Pharma AG & CO KGaA (CHIX:1SXPd) » Definitions » Accounts Payable & Accrued Expense

Schott Pharma AG KGaA (CHIX:1SXPD) Accounts Payable & Accrued Expense : €344.6 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Schott Pharma AG KGaA Accounts Payable & Accrued Expense?

Schott Pharma AG KGaA's quarterly accounts payable & accrued expense increased from Jun. 2024 (€304.4 Mil) to Sep. 2024 (€334.2 Mil) and increased from Sep. 2024 (€334.2 Mil) to Dec. 2024 (€344.6 Mil).

Schott Pharma AG KGaA's annual accounts payable & accrued expense increased from Sep. 2022 (€235.5 Mil) to Sep. 2023 (€251.5 Mil) and increased from Sep. 2023 (€251.5 Mil) to Sep. 2024 (€334.2 Mil).

Schott Pharma AG KGaA Accounts Payable & Accrued Expense Historical Data

The historical data trend for Schott Pharma AG KGaA's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Schott Pharma AG KGaA Accounts Payable & Accrued Expense Chart

Schott Pharma AG KGaA Annual Data
Trend Sep20 Sep21 Sep22 Sep23 Sep24
Accounts Payable & Accrued Expense
163.92 179.83 235.49 251.50 334.24

Schott Pharma AG KGaA Quarterly Data
Sep20 Sep21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 209.96 321.63 304.41 334.24 344.59

Schott Pharma AG KGaA Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Schott Pharma AG KGaA Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Schott Pharma AG & CO KGaA (CHIX:1SXPd) » Definitions » Accounts Payable & Accrued Expense
Comparable Companies
XTER:FIE XTER:AFX XTER:GXI ISRG XPAR:EL BDX XSWX:ALC TSE:7741 RMD TSE:4543 OCSE:COLO B XPAR:DIM XSWX:STMN COO BAX WST ALGN HOLX NZSE:FPH SOLV
Traded in Other Exchanges
SHTPY:USA 1SXP:Germany 1SXP:Austria
Address
Hattenbergstrasse 10, Mainz, RP, DEU, 55122
Website
https://www.schott-pharma.com
Schott Pharma AG & CO KGaA caters to the pharma, biotech and life science industry by providing containment solutions and delivery systems for injectable drugs. Its segments include; Drug Containment Solutions (DCS) and Drug Delivery Systems (DDS). The majority of the revenue is generated from Drug Containment Solutions segment which includes products like vials, cartridges and ampoules for safe drug containment. Geographically, the company generates revenue from Europe, Middle East, Africa (EMEA), Asia and South Pacific, North America and South America.

Schott Pharma AG KGaA Headlines

No Headlines